Michigan State University - Breslin Cancer Center — Lansing, Michigan

Michigan State University - Breslin Cancer Center is a clinical research site located in Lansing, Michigan, United States 48910.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Michigan State University - Breslin Cancer Center has participated in 11 clinical trials.

Therapeutic areas: Breast Cancer, AML, Adult Rhabdomyosarcoma.

Sponsors: NSABP Foundation Inc, Gemin X, Children's Oncology Group.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan State University - Breslin Cancer Center?

Michigan State University - Breslin Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan State University - Breslin Cancer Center conducted?

Michigan State University - Breslin Cancer Center has 11 clinical trials on record. Their work covers Breast Cancer, AML, Adult Rhabdomyosarcoma.

Is Michigan State University - Breslin Cancer Center accredited by Crixeo Health?

Yes — Michigan State University - Breslin Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Michigan State University - Breslin Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.